National Genomic Applications Partnership Program (N-GAPP)
Eligibility & Details
What this program funds and who can apply
Program Description
Funds public-private R&D partnerships to commercialize Canadian genomics and biotech innovations. Genome Canada provides up to one-third of total project costs, with industry and other sources covering the remainder. Projects must be defined by an industry 'Receptor' partner around a real market need with genomics innovation as the core solution.
Eligibility Requirements
- Projects must be co-led by a Canadian academic researcher and a Canadian for-profit enterprise (Receptor)
- Receptor must define the commercial opportunity
- Canadian-domiciled for-profit entities as Receptors
- Project must address a real commercial need identified by industry
- Innovation must be genomics-based or biotechnology-driven
Quick Assessment
Funding Details
- Amount
- $300,000–$2,000,000
- Type
- Grant
- Level
- Federal
- Co-Funding
- Up to 33% of eligible costs
- Deadline
- Between intakes — 2026 LOI cycle closed; next LOI expected April 2027
Program Scorecard
Competition, effort, and approval at a glance
Everything you need to win N-GAPP — $19
Not a marketing summary. The actual checklist, intel, and stack strategy reviewers look for.
- 6-document checklist with what each reviewer is actually checking
- 7-step application timeline with prep hours per step
- Insider tip from program officers on what separates winners
- 5-program stacking strategy to combine with compatible funding
- Success profile + evaluation criteria — exactly what reviewers score on
Applying for N-GAPP? Our Financial Projections Model ($29) covers the cost-share, matching-fund, and cash-flow math reviewers want to see. Or get all 4 templates in the Founder Pack ($59 · saves $27) →
How to Win
Insider tips, common pitfalls, and what successful applicants look like
Insider TipThe single most important factor is a credible, committed industry Receptor — not the research quality. Contact your regional Genome Centre before writing the LOI for free pre-submission feedback. Receptor cash (not in-kind) is weighted most heavily.
Success Profile
Canadian biotech, agri-food, or health sciences company with a specific technology gap that genomics can solve, partnered with an academic lab. Company should have commercial revenue and be prepared to invest cash.
Evaluation Criteria
Three-stage evaluation: (1) LOI assessed on innovation quality, commercial potential, industry Receptor commitment, and alignment with Genome Canada strategic priorities; (2) Full proposal peer-reviewed for scientific merit, commercial viability, team qualifications, budget justification, and IP/commercialization plan; (3) Pitch presentation to review panel. Industry Receptor credibility and cash commitment are weighted most heavily — the commercial pull must be genuine and well-defined.
Application Playbook
Step-by-step process, required documents, and expenses
Application Steps
Required Documents 6
Eligible Expenses 9
- Salaries and benefits for research personnel (academic and industry)
- Graduate student and postdoctoral fellow stipends
- Materials, consumables, and laboratory supplies
- Equipment purchases essential to the project
- Subcontractor fees for specialized services
- Travel for project-related collaboration
- Intellectual property protection costs
- Knowledge translation and dissemination activities
- Project management and coordination costs
Ineligible Expenses 5
- Indirect costs or overhead already covered by institutional support
- Core operating expenses of the company unrelated to the project
- Capital infrastructure or building construction
- Activities completed before the project start date
- Lobbying or government relations activities
Intake Periods
National GAPP (N-GAPP) runs approximately every 2-3 years. N-GAPP 2026 LOI deadline: April 22, 2026. Full proposals due approximately June 2026. Projects start January 2027. Regional GAPP (R-GAPP) runs through individual Genome Centres on separate timelines — contact your regional centre for R-GAPP opportunities.
Deadline Notes
N-GAPP 2026: LOI due to regional Genome Centre by April 22, 2026. Full application due June 2026. Projects start January 2027. Contact your regional Genome Centre (Genome Alberta, Ontario Genomics, Genome Quebec, etc.) before writing the LOI.
Open Application Portal →Ineligible Organizations
- Companies without Canadian domicile or incorporation
- Non-profit organizations acting as sole industry Receptor
- Academic institutions applying without an industry Receptor partner
- Companies with no genuine commercial application for genomics innovation
- Foreign companies without a Canadian subsidiary
Funding Stack Strategy
Compatible programs, clawback risk, and combined funding potential
Compatible Programs
Clawback Risk
Low RiskHow N-GAPP Compares
Side-by-side with similar programs
| Program | Amount | Difficulty | Payment | Deadline |
|---|---|---|---|---|
| National Genomic Applications Partner... | $300,000–$2,000,000 | Hard | Milestone-Based | Between intakes — 2026... |
| Strategic Response Fund (formerly Str... | Up to $50 million | Hard | Mixed (Advance + Reimb.) | Ongoing — continuous... |
| CanExport SMEs | Up to $50,000 | Moderate | Mixed (Advance + Reimb.) | Next deadline: May 29,... |
| Digital Technology Supercluster | Up to $5 million | Hard | Reimbursement | Open — Call for... |
| Ontario Innovation Tax Credit | Up to 8% tax credit | Moderate | Tax Credit Offset | Ongoing |
Related Programs
Other programs you might be eligible for
Frequently Asked Questions
Quick answers to the questions founders most often ask about N-GAPP